RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Weaker technical forecast for TESARO as fund downgraded to Hold/Accumulate.
(Updated on Feb 13, 2019)

Buy or Hold candidate since Nov 19, 2018 PDF

No changes to the price of TESARO fund on the last trading day (Wednesday, 13th Feb 2019). During the last trading day the fund fluctuated 0% from a day low at $74.96 to a day high of $74.96. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

The fund has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $76.71. A reaction back to this level may hold a second chance to get out before further falls.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

TSRO Signals & Forecast

The TESARO fund holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $74.96 and $74.65. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, February 12, 2019, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Support, Risk & Stop-loss for TESARO fund

TESARO finds support from accumulated volume at $73.78 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the fund tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the fund During the last day, the fund moved $0 between high and low, or 0%. For the last week the fund has had daily average volatility of 0%

Our recommended stop-loss: $71.96 (-4.00%) (This fund has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (TSRO) For The Upcoming Trading Day Of Thursday 14th

For the upcoming trading day on Thursday, 14th we expect TESARO to open at $74.96, and during the day (based on 14 day Average True Range), to move between $74.66 and $75.26, which gives a possible trading interval of +/-$0.301 (+/-0.40%) up or down from last closing price. If TESARO takes out the full calculated possible swing range there will be an estimated 0.80% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $73.78, some $1.18 (1.57%) from the current price of $74.96, our system finds the risk reward attractive.

Is TESARO fund A Buy?

TESARO holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this fund since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.590 Hold/Accumulate Downgraded

Predicted Opening Price for TESARO of Thursday, February 14, 2019

Fair opening price February 14, 2019 Current price
$74.96 ( 0%) $74.96

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for TSRO

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 74.96 .
R2 74.96 .
R1 74.96 .
Current price: 74.96
Support S1 74.96 .
S2 74.96 .
S3 74.96 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 74.96
Support S1 73.78 -1.57%
S2 73.69 -1.69%
S3 73.50 -1.95%

FAQ

What is the symbol for TESARO Fund and on which exchange is it traded?
The symbol for TESARO is TSRO and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell TESARO Fund?
TESARO holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this fund since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy TESARO Fund?
TESARO Fund can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy TESARO Fund.

What's the current price of TESARO Fund?
As of the end of day on the 2019-02-13, the price of an TESARO (TSRO) share was $74.96.

What is the 52-week high and low for TESARO Fund?
The 52-week high for TESARO Fund is $75.16 and the 52-week low is $23.41.
Click to get the best stock tips daily for free!

About TESARO

TESARO, Inc., an oncology-focused biopharmaceutical company, identifies, acquires, develops, and commercializes cancer therapeutics and oncology supportive care products in the United States and internationally. Its product portfolio consist of Rolapitant, a neurokinin-1 receptor antagonist, which is in phase 1 intravenous clinical trials for the prevention of chemotherapy induced nausea and vomiting; Niraparib, an orally active and potent poly p... TSRO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT